إعلان
إعلان
RCKT
Rocket Pharmaceuticals, Inc. Common Stock
3.52
USDبرعاية
+0.06
+1.59%
٠٥ يناير, ٠٩:٣٥ UTC -5
مفتوح
تقارير أرباح RCKT
النسبة الإيجابية المفاجئة
RCKT تفوق 24 من 38 آخر التقديرات.
63%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.44
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-2.22%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-29.03%
Rocket Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, RCKT reported earnings of -0.45 USD per share (EPS) for Q3 25, beating the estimate of -0.51 USD, resulting in a 12.64% surprise. Revenue reached --, compared to an expected 283.33 ألف, with a -100.00% difference. The market reacted with a -1.86% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 المحللين forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an نقصان of -2.22% EPS, and زيادة of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Rocket Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Rocket Pharmaceuticals, Inc. Common Stock reported EPS of -$0.45, beating estimates by 12.64%, and revenue of $0.00, -100% below expectations.
How did the market react to Rocket Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.86%, changed from $3.23 before the earnings release to $3.17 the day after.
When is Rocket Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for Rocket Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 16
المحللين, Rocket Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.44 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان